Product Introduction: DAPANTA 10

DAPANTA 10 is a widely prescribed oral antidiabetic medication manufactured by Ajantha. Composed of 10mg of Dapagliflozin, this tablet is indicated for glycemic control in adult patients diagnosed with Type 2 Diabetes Mellitus. When used alongside a balanced diet and regular physical exercise, it helps regulate blood glucose levels.

Primary Indications

• Management of Type 2 Diabetes Mellitus in adults for optimal glycemic control.
• Improving insulin sensitivity and restricting renal glucose reabsorption.
• Reducing the risk of hospitalization for heart failure in patients with Type 2 Diabetes.

Clinical Benefits

• HbA1c Optimization: Assists in achieving and maintaining target HbA1c (glycosylated hemoglobin) levels.
• Weight & BP Reductions: Promotes calorie loss and blood pressure reduction through excretion of glucose in urine.
• Cardioprotection: Proven cardiorenal benefits in patients with diabetes and heart failure.

Possible Side Effects

Common side effects may include:

• Genitourinary tract infections (such as vulvovaginal candidiasis or urinary tract infections) due to glucose in urine.
• Dehydration, orthostatic hypotension, or increased urination.
• Nasopharyngitis, headache, or dizziness.

How to Take DAPANTA 10

• Take the tablet once daily, preferably in the morning, with or without food.
• Swallow the tablet whole with a glass of water. Do not crush, chew, or split.
• Maintain adequate hydration to prevent dehydration and urinary tract infections.

Mechanism of Action

DAPANTA 10 contains Dapagliflozin, which is a selective, competitive sodium-glucose cotransporter 2 (SGLT2) inhibitor. SGLT2 is expressed in the proximal renal tubules and is responsible for the majority of glomerular glucose reabsorption. By inhibiting SGLT2, Dapagliflozin reduces renal glucose reabsorption, promoting urinary glucose excretion.

Safety Warnings

• Renal Function: Dapagliflozin efficacy is dependent on kidney function. Avoid in severe renal impairment.
• Diabetic Ketoacidosis (DKA): SGLT2 inhibitors carry a rare risk of atypical euglycemic DKA. Monitor symptoms.
• Pregnancy & Nursing: Strictly contraindicated. Avoid use.

Patient Advice

• Maintain high standards of personal hygiene to prevent genital fungal infections.
• Drink plenty of water (8-10 glasses) daily to stay well-hydrated.
• Ensure regular monitoring of kidney function, electrolytes, and HbA1c levels.

Fact Box

Drug Interactions

• Insulin & Sulfonylureas: Concomitant use increases the risk of hypoglycemia; lower doses may be required.
• Diuretics (Loop): May increase the risk of dehydration and hypotension.

User Feedback

• Patients report excellent control of blood glucose levels, with many noting beneficial weight loss and cardiovascular stability.
• Highly recommended by endocrinologists as a premium oral monotherapy option.